ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ImmunoChemoradiation for Non-Small Cell Lung Cancer: A Meta-Analysis of Factors Influencing Survival Benefit in Combination Trials

Published:2024-10 Issue:2 Volume:120 Page:409-421
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Huang Huei-Tyng,Brand Douglas H.,Fenwick John D.,Hawkins Maria A.^ORCID

Funder

NIHR UCLH BRC

Publisher

Elsevier BV

Reference35 articles.

1. Cancer progress and priorities: Lung cancer;Schabath;Cancer Epidemiol Biomarkers Prev,2019

2. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Van Schil;Ann Oncol,2018

3. Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review;Zehentmayr;Thorac Cancer,2020

4. Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: Meta-analysis of randomized trials;Ramroth;Int J Radiat Oncol Biol Phys,2016

5. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;New Engl J Med,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing;Radiotherapy and Oncology;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP